Literature DB >> 8195930

Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland.

R Holm1, J M Nesland.   

Abstract

One hundred and thirty-one thyroid tumours were examined immunohistochemically for expression of retinoblastoma (RB) and p53 protein. The results demonstrate that RB protein is not lost in any cases, indicating that inactivation of the RB gene is unlikely to play a central role in the pathogenesis of thyroid tumours. Eighteen of 24 (75 per cent) undifferentiated carcinomas, 6 of 32 (19 per cent) papillary carcinomas, 5 of 29 (17 per cent) follicular carcinomas, and 6 of 46 (13 per cent) medullary carcinomas showed p53 protein nuclear staining. In 46 per cent of the undifferentiated carcinomas many of the tumour cells had accumulated p53 protein, whereas in the other positive cases less than 5 per cent of the cells had increased p53 protein levels. Our results strongly suggest that p53 protein abnormalities play a crucial role in the progression of well-differentiated to undifferentiated thyroid carcinomas.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195930     DOI: 10.1002/path.1711720307

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  14 in total

Review 1.  Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects.

Authors:  N J Sarlis
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

2.  Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas.

Authors:  K M La Perle; S M Jhiang; C C Capen
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21.

Authors:  K Y Lam; C Y Lo; K W Chan; K Y Wan
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

4.  Paucicellular variant of anaplastic thyroid carcinoma: report of two cases.

Authors:  J C Canos; A Serrano; X Matias-Guiu
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

5.  Cyclin D1 and retinoblastoma protein expression in oesophageal squamous cell carcinoma.

Authors:  R Chetty; S Chetty
Journal:  Mol Pathol       Date:  1997-10

Review 6.  Molecular pathobiology of thyroid neoplasms.

Authors:  Giovanni Tallini
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

7.  Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.

Authors:  F M Michiels; S Chappuis; B Caillou; A Pasini; M Talbot; R Monier; G M Lenoir; J Feunteun; M Billaud
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

Review 8.  Thyroid C-Cell Biology and Oncogenic Transformation.

Authors:  Gilbert J Cote; Elizabeth G Grubbs; Marie-Claude Hofmann
Journal:  Recent Results Cancer Res       Date:  2015

9.  Up-regulation of transcriptional factor E2F1 in papillary and anaplastic thyroid cancers.

Authors:  Masamitsu Onda; Hisaki Nagai; Akira Yoshida; Shizuyo Miyamoto; Shin-Ichi Asaka; Junko Akaishi; Keisuke Takatsu; Mitsuji Nagahama; Kouichi Ito; Kazuo Shimizu; Mitsuru Emi
Journal:  J Hum Genet       Date:  2004-04-29       Impact factor: 3.172

10.  Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer.

Authors:  Anisley Valenciaga; Elizabeth G Grubbs; Kyle Porter; Paul E Wakely; Michelle D Williams; Gilbert J Cote; Vasyl V Vasko; Motoyasu Saji; Matthew D Ringel
Journal:  Thyroid       Date:  2017-12       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.